Tylenol is in short supply for a long time

Pharmaceutical companies seeking reflective interests

Due to the issue of vaccine side effects and government guidance, Tylenol is becoming increasingly scarce in pharmacies

Along with the issue of side effects of COVID-19 vaccines in pharmacies, the shortage of Tylenol is intensifying.

 

Domestic companies with generic products are expecting reflective profits.

 

Several companies are said to have started marketing related to Tylenol shortages so that they can lead to increased sales of other generics of acetaminophen.

 

Tylenol

According to the pharmaceutical industry on the 14th, Tylenol has become more scarce in outpatient pharmacies over the past month.

 

In the case of Tylenol and Tylenol 8-hour ER, it is confirmed that they are completely out of stock at online malls exclusively for major pharmacies.

 

Analysts say that the issue of side effects of COVID-19 vaccine and the government's guidance have caused a shortage.

 

As the number of people vaccinated against COVID-19 increased, the side effects of fever and muscle pain increased, and more people wanted to buy Tylenol.

 

In addition, the quarantine authorities guided, "If fever occurs after vaccination, it is recommended to take fever reducer such as Tylenol," and most pharmacies are now unable to find Tylenol.

 

Pharmacists are recommending generic products instead of original Tylenol.

 

A pharmacist who runs a pharmacy in Seoul said, "The number of people looking for Tylenol has more than doubled than usual," adding, "We recommend generics because Tylenol is not available." "If the number of people vaccinated against COVID-19 increases in the future, sales of generic products will increase." Another pharmacist in Daejeon said, "We're barely getting Tylenol.

 

I think it's been about a month.

 

Wholesale stores offer limited supplies to each pharmacy.

 

If generics are recommended, one to two out of 10 people buy the drug." As the shortage of Tylenol intensifies, its effects are gradually expanding to other generics.

 

Sales of Samjin's Geworin, Jong Kun Dang's PENZAL-Q, Dong-A's Panpyrin, and Daewoong's EZN6 Ace, which include the same ingredients as Tylenol, are reportedly increasing little by little.

 

Geworin Cooldown

Korean companies are also starting related marketing in line with this trend.

 

Emphasizing that it is the generics for those who have not obtained Tylenol, it is necessary to prepare for the possibility of side effects after vaccination.

 

In the case of Geworin, sales volume is said to have increased slightly last month due to the issue of side effects of vaccines.

 

"We are pushing for Geworin Cooldown as a product to prepare for side effects of the vaccine," said a representative for Samjin.

 

"It is true that sales have increased compared to the past." "In the case of Geworin Cooldown, the number of new businesses is increasing just after its release.

 

"We understand the impact of this, the issue of side effects of vaccines, and the result of marketing." An official from Dong-A said, "Panpyrin's sales have increased a little compared to last year," adding, "However, it is too much to blame only the issue of side effects of vaccines." "It's Acetaminophen, but it's more widely known as a cold medicine than a pain reliever.

 

"In case of PENZAL, there is little change in sales compared to the past," said a representative for Chong Kun Dang.

 

"There is a possibility that sales will increase as the number of people vaccinated against COVID-19 increases."